Etienne Hirsch

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Rolland Anne-Sophie; Tandé Dominique; Herrero Maria-Trinidad; Luquin Maria-Rosario; Vazquez-Claverie Marianne; Karachi Carine; Hirsch Etienne C; François Chantal
Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Karachi Carine; Grabli David; Baup Nicolas; Mounayar Stéphanie; Tandé Dominique; François Chantal; Hirsch Etienne C
Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys.
Guerreiro Serge; Ponceau Aurélie; Toulorge Damien; Martin Elodie; Alvarez-Fischer Daniel; Hirsch Etienne C; Michel Patrick P
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Etienne Hirsch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rolland Anne-Sophie; Tandé Dominique; Herrero Maria-Trinidad; Luquin Maria-Rosario; Vazquez-Claverie Marianne; Karachi Carine; Hirsch Etienne C; François Chantal
Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication.
Journal of neurochemistry 2009;110(4):1321-9.
2009: Karachi Carine; Grabli David; Baup Nicolas; Mounayar Stéphanie; Tandé Dominique; François Chantal; Hirsch Etienne C
Dysfunction of the subthalamic nucleus induces behavioral and movement disorders in monkeys.
Movement disorders : official journal of the Movement Disorder Society 2009;24(8):1183-92.
2009: Guerreiro Serge; Ponceau Aurélie; Toulorge Damien; Martin Elodie; Alvarez-Fischer Daniel; Hirsch Etienne C; Michel Patrick P
Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.
Journal of neurochemistry 2009;109(4):1118-28.
2009: Hirsch Etienne C; Hunot Stéphane
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Lancet neurology 2009;8(4):382-97.
2009: Brochard Vanessa; Combadière Béhazine; Prigent Annick; Laouar Yasmina; Perrin Aline; Beray-Berthat Virginie; Bonduelle Olivia; Alvarez-Fischer Daniel; Callebert Jacques; Launay Jean-Marie; Duyckaerts Charles; Flavell Richard A; Hirsch Etienne C; Hunot Stéphane
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
The Journal of clinical investigation 2009;119(1):182-92.
2008: Salazar Julio; Mena Natalia; Hunot Stephane; Prigent Annick; Alvarez-Fischer Daniel; Arredondo Miguel; Duyckaerts Charles; Sazdovitch Veronique; Zhao Lin; Garrick Laura M; Nuñez Marco T; Garrick Michael D; Raisman-Vozari Rita; Hirsch Etienne C
Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(47):18578-83.
2008: Alvarez-Fischer Daniel; Guerreiro Serge; Hunot Stéphane; Saurini Françoise; Marien Marc; Sokoloff Pierre; Hirsch Etienne C; Hartmann Andreas; Michel Patrick P
Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.
Journal of neurochemistry 2008;107(3):701-11.
2008: Guerreiro Serge; Toulorge Damien; Hirsch Etienne; Marien Marc; Sokoloff Pierre; Michel Patrick P
Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.
Molecular pharmacology 2008;74(4):980-9.
2008: Boulet Sabrina; Mounayar Stéphanie; Poupard Annie; Bertrand Anne; Jan Caroline; Pessiglione Mathias; Hirsch Etienne C; Feuerstein Claude; François Chantal; Féger Jean; Savasta Marc; Tremblay Léon
Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(38):9575-84.
2007: Mounayar Stéphanie; Boulet Sabrina; Tandé Dominique; Jan Caroline; Pessiglione Mathias; Hirsch Etienne C; Féger Jean; Savasta Marc; François Chantal; Tremblay Léon
A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery.
Brain : a journal of neurology 2007;130(Pt 11):2898-914.
2007: Escobar-Khondiker Myriam; Höllerhage Matthias; Muriel Marie-Paule; Champy Pierre; Bach Antoine; Depienne Christel; Respondek Gesine; Yamada Elizabeth S; Lannuzel Annie; Yagi Takao; Hirsch Etienne C; Oertel Wolfgang H; Jacob Ralf; Michel Patrick P; Ruberg Merle; Höglinger Günter U
Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(29):7827-37.
2007: Ginestet Laure; Ferrario Juan E; Raisman-Vozari Rita; Hirsch Etienne C; Debeir Thomas
Donepezil induces a cholinergic sprouting in basocortical degeneration.
Journal of neurochemistry 2007;102(2):434-40.
2007: Michel Patrick P; Alvarez-Fischer Daniel; Guerreiro Serge; Hild Audrey; Hartmann Andreas; Hirsch Etienne C
Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.
Journal of neurochemistry 2007;101(2):289-97.
2007: Nait-Oumesmar Brahim; Picard-Riera Nathalie; Kerninon Christophe; Decker Laurence; Seilhean Danielle; Höglinger Günter U; Hirsch Etienne C; Reynolds Richard; Baron-Van Evercooren Anne
Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(11):4694-9.
2007: Lannuzel Annie; Höglinger G U; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel W H; Hirsch E C; Dubois B; Ruberg M
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Brain : a journal of neurology 2007;130(Pt 3):816-27.
2007: Höglinger Günter U; Breunig Joshua J; Depboylu Candan; Rouaux Caroline; Michel Patrick P; Alvarez-Fischer Daniel; Boutillier Anne-Laurence; Degregori James; Oertel Wolfgang H; Rakic Pasko; Hirsch Etienne C; Hunot Stéphane
The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3585-90.
2007: Rolland Anne-Sophie; Herrero Maria-Trinidad; Garcia-Martinez Virginia; Ruberg Merle; Hirsch Etienne C; François Chantal
Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
Brain : a journal of neurology 2007;130(Pt 1):265-75.
2007: Hirsch E C
How to improve neuroprotection in Parkinson's disease?
Parkinsonism & related disorders 2007;13 Suppl 3():S332-5.
2007: Hirsch E C
Animal models in neurodegenerative diseases.
Journal of neural transmission. Supplementum 2007;(72):87-90.
2007: Jan C; Muriel M-P; Rolland A-S; Hirsch E C; François C
Localization of D1a dopamine receptors on cell bodies and axonal endings in the substantia nigra pars reticulata of the rat.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(12):1509-17.
2006: Lu Lixia; Neff Frauke; Fischer Daniel Alvarez; Henze Carmen; Hirsch Etienne C; Oertel Wolfgang H; Schlegel Jürgen; Hartmann Andreas
Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
Neurobiology of disease 2006;23(2):409-21.
2006: Traver Sabine; Marien Marc; Martin Elodie; Hirsch Etienne C; Michel Patrick P
The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
Molecular pharmacology 2006;70(1):30-40.
2006: Borrell-Pagès Maria; Canals Josep M; Cordelières Fabrice P; Parker J Alex; Pineda José R; Grange Ghislaine; Bryson Elzbieta A; Guillermier Martine; Hirsch Etienne; Hantraye Philippe; Cheetham Michael E; Néri Christian; Alberch Jordi; Brouillet Emmanuel; Saudou Frédéric; Humbert Sandrine
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
The Journal of clinical investigation 2006;116(5):1410-24.
2006: Tandé Dominique; Höglinger Günter; Debeir Thomas; Freundlieb Nils; Hirsch Etienne C; François Chantal
New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis.
Brain : a journal of neurology 2006;129(Pt 5):1194-200.
2006: Michel Patrick P; Ruberg Merle; Hirsch Etienne
Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
Science's STKE : signal transduction knowledge environment 2006;2006(332):pe19.
2006: Benchoua Alexandra; Trioulier Yaël; Zala Diana; Gaillard Marie-Claude; Lefort Nathalie; Dufour Noelle; Saudou Frederic; Elalouf Jean-Marc; Hirsch Etienne; Hantraye Philippe; Déglon Nicole; Brouillet Emmanuel
Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
Molecular biology of the cell 2006;17(4):1652-63.
2006: Freundlieb Nils; François Chantal; Tandé Dominique; Oertel Wolfgang H; Hirsch Etienne C; Höglinger Günter U
Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(8):2321-5.
2006: Tandé Dominique; Féger Jean; Hirsch Etienne C; François Chantal
Parafascicular nucleus projection to the extrastriatal basal ganglia in monkeys.
Neuroreport 2006;17(3):277-80.
2006: Hirsch E C
Altered regulation of iron transport and storage in Parkinson's disease.
Journal of neural transmission. Supplementum 2006;(71):201-4.
2006: Höglinger G U; Oertel W H; Hirsch E C
The rotenone model of parkinsonism--the five years inspection.
Journal of neural transmission. Supplementum 2006;(70):269-72.
2006: Lannuzel A; Höglinger G U; Champy P; Michel P P; Hirsch E C; Ruberg M
Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?
Journal of neural transmission. Supplementum 2006;(70):153-7.
2005: Höglinger Günter U; Lannuzel Annie; Khondiker Myriam Escobar; Michel Patrick P; Duyckaerts Charles; Féger Jean; Champy Pierre; Prigent Annick; Medja Fadia; Lombes Anne; Oertel Wolfgang H; Ruberg Merle; Hirsch Etienne C
The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.
Journal of neurochemistry 2005;95(4):930-9.
2005: Henze Carmen; Hartmann Andreas; Lescot Thomas; Hirsch Etienne C; Michel Patrick P
Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism: role of granulocyte macrophage colony-stimulating factor.
Journal of neurochemistry 2005;95(4):1069-77.
2005: Salthun-Lassalle Bénédicte; Traver Sabine; Hirsch Etienne C; Michel Patrick P
Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism.
Molecular pharmacology 2005;68(5):1214-24.
2005: Barcia C; Bautista V; Sánchez-Bahillo A; Fernández-Villalba E; Faucheux B; Poza y Poza M; Fernandez Barreiro A; Hirsch E C; Herrero M-T
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(9):1237-48.
2005: Henze Carmen; Lescot Thomas; Traver Sabine; Salthun-Lassalle Bénédicte; Hirsch Etienne C; Michel Patrick P; Hartmann Andreas
Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro.
Neuroscience letters 2005;383(1-2):44-8.
2005: Hirsch Etienne C; Hunot Stéphane; Hartmann Andreas
Neuroinflammatory processes in Parkinson's disease.
Parkinsonism & related disorders 2005;11 Suppl 1():S9-S15.
2005: Traver Sabine; Salthun-Lassalle Bénédicte; Marien Marc; Hirsch Etienne C; Colpaert Francis; Michel Patrick P
The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress.
Molecular pharmacology 2005;67(6):1882-91.
2005: Pessiglione Mathias; Guehl Dominique; Rolland Anne-Sophie; François Chantal; Hirsch Etienne C; Féger Jean; Tremblay Léon
Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(6):1523-31.
2005: Karachi Carine; Yelnik Jérôme; Tandé Dominique; Tremblay Léon; Hirsch Etienne C; François Chantal
The pallidosubthalamic projection: an anatomical substrate for nonmotor functions of the subthalamic nucleus in primates.
Movement disorders : official journal of the Movement Disorder Society 2005;20(2):172-80.
2005: Höglinger Günter U; Michel Patrick P; Champy Pierre; Feger Jean; Hirsch Etienne C; Ruberg Merle; Lannuzel Annie
Experimental evidence for a toxic etiology of tropical parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 2005;20(1):118-9.
2004: Mouatt-Prigent A; Muriel M-P; Gu W-J; El Hachimi K H; Lücking C B; Brice A; Hirsch E C
Ultrastructural localization of parkin in the rat brainstem, thalamus and basal ganglia.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(10-11):1209-18.
2004: François Chantal; Grabli David; McCairn Kevin; Jan Caroline; Karachi Carine; Hirsch Etienne-C; Féger Jean; Tremblay Léon
Behavioural disorders induced by external globus pallidus dysfunction in primates II. Anatomical study.
Brain : a journal of neurology 2004;127(Pt 9):2055-70.
2004: Grabli David; McCairn Kevin; Hirsch Etienne C; Agid Yves; Féger Jean; François Chantal; Tremblay Léon
Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study.
Brain : a journal of neurology 2004;127(Pt 9):2039-54.
2004: Corvol Jean-Christophe; Muriel Marie-Paule; Valjent Emmanuel; Féger Jean; Hanoun Naïma; Girault Jean-Antoine; Hirsch Etienne C; Hervé Denis
Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(31):7007-14.
2004: Höglinger Günter U; Rizk Pamela; Muriel Marie P; Duyckaerts Charles; Oertel Wolfgang H; Caille Isabelle; Hirsch Etienne C
Dopamine depletion impairs precursor cell proliferation in Parkinson disease.
Nature neuroscience 2004;7(7):726-35.
2004: Salthun-Lassalle Bénédicte; Hirsch Etienne C; Wolfart Jakob; Ruberg Merle; Michel Patrick P
Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(26):5922-30.
2004: Barcia Carlos; Sánchez Bahillo Angel; Fernández-Villalba Emiliano; Bautista Víctor; Poza Y Poza Máximo; Fernández-Barreiro Andrés; Hirsch Etienne C; Herrero María-Trinidad
Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.
Glia 2004;46(4):402-9.
2004: Barcia Carlos; Emborg Marina E; Hirsch Etienne C; Herrero María-Trinidad
Blood vessels and parkinsonism.
Frontiers in bioscience : a journal and virtual library 2004;9():277-82.
2004: Pessiglione Mathias; Guehl Dominique; Jan Caroline; François Chantal; Hirsch Etienne C; Féger Jean; Tremblay Léon
Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism: II. Effects of reward preference.
The European journal of neuroscience 2004;19(2):437-46.
2004: Pessiglione Mathias; Guehl Dominique; Hirsch Etienne C; Féger Jean; Tremblay Léon
Disruption of self-organized actions in monkeys with progressive MPTP-induced parkinsonism. I. Effects of task complexity.
The European journal of neuroscience 2004;19(2):426-36.
2004: Hunot Stéphane; Vila Miquel; Teismann Peter; Davis Roger J; Hirsch Etienne C; Przedborski Serge; Rakic Pasko; Flavell Richard A
JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(2):665-70.
2004: Champy Pierre; Höglinger Günter U; Féger Jean; Gleye Christophe; Hocquemiller Reynald; Laurens Alain; Guérineau Vincent; Laprévote Olivier; Medja Fadia; Lombès Anne; Michel Patrick P; Lannuzel Annie; Hirsch Etienne C; Ruberg Merle
Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe.
Journal of neurochemistry 2004;88(1):63-9.
2003: Hartmann Andreas; Hunot Stéphane; Hirsch Etienne C
Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
Experimental neurology 2003;184(2):561-4.
2003: Rousselet Estelle; Joubert Chantal; Callebert Jacques; Parain Karine; Tremblay Léon; Orieux Gaël; Launay Jean-Marie; Cohen-Salmon Charles; Hirsch Etienne C
Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice.
Neurobiology of disease 2003;14(2):218-28.
2003: Jan Caroline; Pessiglione Mathias; Tremblay Léon; Tandé Dominique; Hirsch Etienne C; François Chantal
Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys.
The European journal of neuroscience 2003;18(7):2082-6.
2003: Gourfinkel-An I; Parain K; Hartmann A; Mangiarini L; Brice A; Bates G; Hirsch E C
Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6/2 transgenic mice.
Journal of neurochemistry 2003;86(6):1369-78.
2003: Périer Céline; Marin Concepció; Jimenez Anna; Bonastre Mercè; Tolosa Eduardo; Hirsch Etienne C
Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
Journal of neurochemistry 2003;86(6):1328-37.
2003: Parain Karine; Hapdey Céline; Rousselet Estelle; Marchand Véronique; Dumery Bernard; Hirsch Etienne C
Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin.
Brain research 2003;984(1-2):224-32.
2003: Höglinger Günter U; Carrard Géraldine; Michel Patrick P; Medja Fadia; Lombès Anne; Ruberg Merle; Friguet Bertrand; Hirsch Etienne C
Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.
Journal of neurochemistry 2003;86(5):1297-307.
2003: Faucheux Baptiste A; Martin Marie-Elise; Beaumont Carole; Hauw Jean-Jacques; Agid Yves; Hirsch Etienne C
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
Journal of neurochemistry 2003;86(5):1142-8.
2003: Hirsch E C; Breidert T; Rousselet E; Hunot S; Hartmann A; Michel P P
The role of glial reaction and inflammation in Parkinson's disease.
Annals of the New York Academy of Sciences 2003;991():214-28.
2003: Guehl D; Pessiglione M; François C; Yelnik J; Hirsch E C; Féger J; Tremblay L
Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonism.
The European journal of neuroscience 2003;17(11):2388-400.
2003: Corti Olga; Hampe Cornelia; Koutnikova Hana; Darios Frédéric; Jacquier Sandrine; Prigent Annick; Robinson Jean-Charles; Pradier Laurent; Ruberg Merle; Mirande Marc; Hirsch Etienne; Rooney Thomas; Fournier Alain; Brice Alexis
The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
Human molecular genetics 2003;12(12):1427-37.
2003: Pessiglione Mathias; Guehl Dominique; Agid Yves; Hirsch Etienne C; Féger Jean; Tremblay Léon
Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease.
Brain : a journal of neurology 2003;126(Pt 6):1392-408.
2003: Darios Frédéric; Corti Olga; Lücking Christoph B; Hampe Cornelia; Muriel Marie-Paule; Abbas Nacer; Gu Wen-Jie; Hirsch Etienne C; Rooney Thomas; Ruberg Merle; Brice Alexis
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death.
Human molecular genetics 2003;12(5):517-26.
2003: Höglinger Günter U; Féger Jean; Prigent Annick; Michel Patrick P; Parain Karine; Champy Pierre; Ruberg Merle; Oertel Wolfgang H; Hirsch Etienne C
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Journal of neurochemistry 2003;84(3):491-502.
2003: Lannuzel A; Michel P P; Höglinger G U; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch E C; Ruberg M
The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
Neuroscience 2003;121(2):287-96.
2003: Hirsch E C; Höglinger G; Rousselet E; Breidert T; Parain K; Feger J; Ruberg M; Prigent A; Cohen-Salmon C; Launay J M
Animal models of Parkinson's disease in rodents induced by toxins: an update.
Journal of neural transmission. Supplementum 2003;(65):89-100.
2003: Hunot Stephane; Hirsch E C
Neuroinflammatory processes in Parkinson's disease.
Annals of neurology 2003;53 Suppl 3():S49-58; discussion S58-60.
2003: Hirsch E C; Orieux G; Muriel M-P; Francois C; Feger J
Nondopaminergic neurons in Parkinson's disease.
Advances in neurology 2003;91():29-37.
2002: Michel P P; Hirsch E C; Agid Y
[Parkinson disease: mechanisms of cell death]
Revue neurologique 2002;158 Spec no 1():S24-32.
2002: Périer Céline; Marin Concepció; Bonastre Mercè; Tolosa Eduardo; Hirsch Etienne C
AMPA receptor antagonist LY293558 reverses preproenkephalin mRNA overexpression in the striatum of 6-OHDA-lesioned-rats treated with L-dopa.
The European journal of neuroscience 2002;16(11):2236-40.
2002: Muriel Marie-Paule; Orieux Gaël; Hirsch Etienne C
Levodopa but not ropinirole induces an internalization of D1 dopamine receptors in parkinsonian rats.
Movement disorders : official journal of the Movement Disorder Society 2002;17(6):1174-9.
2002: Faucheux Baptiste A; Martin Marie-Elise; Beaumont Carole; Hunot Stéphane; Hauw Jean-Jacques; Agid Yves; Hirsch Etienne C
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease.
Journal of neurochemistry 2002;83(2):320-30.
2002: Orieux Gaël; François Chantal; Féger Jean; Hirsch Etienne C
Consequences of dopaminergic denervation on the metabolic activity of the cortical neurons projecting to the subthalamic nucleus in the rat.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(19):8762-70.
2002: Périer Céline; Tremblay Léon; Féger Jean; Hirsch Etienne C
Behavioral consequences of bicuculline injection in the subthalamic nucleus and the zona incerta in rat.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(19):8711-9.
2002: Rousselet Estelle; Callebert Jacques; Parain Karine; Joubert Chantal; Hunot Stéphane; Hartmann Andreas; Jacque Claude; Perez-Diaz Fernando; Cohen-Salmon Charles; Launay Jean-Marie; Hirsch Etienne C
Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP.
Experimental neurology 2002;177(1):183-92.
2002: Breidert T; Callebert J; Heneka M T; Landreth G; Launay J M; Hirsch E C
Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
Journal of neurochemistry 2002;82(3):615-24.
2002: Karachi Carine; François Chantal; Parain Karine; Bardinet Eric; Tandé Dominique; Hirsch Etienne; Yelnik Jérôme
Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity.
The Journal of comparative neurology 2002;450(2):122-34.
2002: Hartmann Andreas; Mouatt-Prigent Annick; Vila Miquel; Abbas Nacer; Perier Céline; Faucheux Baptiste A; Vyas Sheela; Hirsch Etienne C
Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.
Neurobiology of disease 2002;10(1):28-32.
2002: François Chantal; Tande Dominique; Yelnik Jerome; Hirsch Etienne C
Distribution and morphology of nigral axons projecting to the thalamus in primates.
The Journal of comparative neurology 2002;447(3):249-60.
2002: Gourfinkel-An Isabelle; Vila Miquel; Faucheux Baptiste; Duyckaerts Charles; Viallet François; Hauw Jean-Jacques; Brice Alexis; Agid Yves; Hirsch Etienne C
Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
Journal of neurochemistry 2002;80(3):466-76.
2002: Féger J; Pessigliore M; François C; Tremblay L; Hirsch E
[Experimental models of Parkinson's disease]
Annales pharmaceutiques françaises 2002;60(1):3-21.
2002: Hartmann A; Mouatt-Prigent A; Faucheux B A; Agid Y; Hirsch E C
FADD: A link between TNF family receptors and caspases in Parkinson's disease.
Neurology 2002;58(2):308-10.
2001: Marin C; Jiménez A; Bonastre M; Vila M; Agid Y; Hirsch E C; Tolosa E
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats.
Synapse (New York, N.Y.) 2001;42(1):40-7.
2001: Baulac S; Picard F; Herman A; Feingold J; Genin E; Hirsch E; Prud'homme J F; Baulac M; Brice A; LeGuern E
Evidence for digenic inheritance in a family with both febrile convulsions and temporal lobe epilepsy implicating chromosomes 18qter and 1q25-q31.
Annals of neurology 2001;49(6):786-92.
2001: Muriel M P; Agid Y; Hirsch E
Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):435-41.
2001: Bensaid M; Faucheux B A; Hirsch E; Agid Y; Soubrié P; Oury-Donat F
Expression of tachykinin NK2 receptor mRNA in human brain.
Neuroscience letters 2001;303(1):25-8.
2001: Hartmann A; Troadec J D; Hunot S; Kikly K; Faucheux B A; Mouatt-Prigent A; Ruberg M; Agid Y; Hirsch E C
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(7):2247-55.
2001: Zarate-Lagunes M; Gu W J; Blanchard V; Francois C; Muriel M P; Mouatt-Prigent A; Bonici B; Parent A; Hartmann A; Yelnik J; Boehme G A; Pradier L; Moussaoui S; Faucheux B; Raisman-Vozari R; Agid Y; Brice A; Hirsch E C
Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes.
The Journal of comparative neurology 2001;432(2):184-96.
2001: Turmel H; Hartmann A; Parain K; Douhou A; Srinivasan A; Agid Y; Hirsch E C
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
Movement disorders : official journal of the Movement Disorder Society 2001;16(2):185-9.
2001: Hartmann A; Michel P P; Troadec J D; Mouatt-Prigent A; Faucheux B A; Ruberg M; Agid Y; Hirsch E C
Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Journal of neurochemistry 2001;76(6):1785-93.
2001: Parain K; Marchand V; Dumery B; Hirsch E
Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice.
Brain research 2001;890(2):347-50.
2001: Hartmann A; Hirsch E C
Parkinson's disease. The apoptosis hypothesis revisited.
Advances in neurology 2001;86():143-53.
2000: Jan C; François C; Tandé D; Yelnik J; Tremblay L; Agid Y; Hirsch E
Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
The European journal of neuroscience 2000;12(12):4525-35.
2000: Cancel G; Duyckaerts C; Holmberg M; Zander C; Yvert G; Lebre A S; Ruberg M; Faucheux B; Agid Y; Hirsch E; Brice A
Distribution of ataxin-7 in normal human brain and retina.
Brain : a journal of neurology 2000;123 Pt 12():2519-30.
2000: Hirsch E C; Hunot S; Hartmann A
Mechanism of cell death in experimental models of Parkinson's disease.
Functional neurology 2000;15(4):229-37.
2000: Hirsch E C; Périer C; Orieux G; François C; Féger J; Yelnik J; Vila M; Levy R; Tolosa E S; Marin C; Trinidad Herrero M; Obeso J A; Agid Y
Metabolic effects of nigrostriatal denervation in basal ganglia.
Trends in neurosciences 2000;23(10 Suppl):S78-85.
2000: Dubus P; Faucheux B; Boissière F; Groppi A; Vital C; Vital A; Agid Y; Hirsch E C; Merlio J P
Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease.
Experimental neurology 2000;165(2):285-94.
2000: Muriel M P; Lambeng N; Darios F; Michel P P; Hirsch E C; Agid Y; Ruberg M
Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death.
The Journal of comparative neurology 2000;426(2):297-315.
2000: Périer C; Agid Y; Hirsch E C; Féger J
Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion.
Neuroreport 2000;11(14):3275-8.
2000: François C; Savy C; Jan C; Tande D; Hirsch E C; Yelnik J
Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients.
The Journal of comparative neurology 2000;425(1):121-9.
2000: Ransmayr G; Faucheux B; Nowakowski C; Kubis N; Federspiel S; Kaufmann W; Henin D; Hauw J J; Agid Y; Hirsch E C
Age-related changes of neuronal counts in the human pedunculopontine nucleus.
Neuroscience letters 2000;288(3):195-8.
2000: Picard F; Baulac S; Kahane P; Hirsch E; Sebastianelli R; Thomas P; Vigevano F; Genton P; Guerrini R; Gericke C A; An I; Rudolf G; Herman A; Brice A; Marescaux C; LeGuern E
Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families.
Brain : a journal of neurology 2000;123 ( Pt 6)():1247-62.
2000: Hirsch E C; Hunot S
Nitric oxide, glial cells and neuronal degeneration in parkinsonism.
Trends in pharmacological sciences 2000;21(5):163-5.
2000: Hirsch E C
Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
Annals of neurology 2000;47(4 Suppl 1):S115-20; discussion S120-1.
2000: Gu W J; Abbas N; Lagunes M Z; Parent A; Pradier L; Bohme G A; Agid Y; Hirsch E C; Raisman-Vozari R; Brice A
Cloning of rat parkin cDNA and distribution of parkin in rat brain.
Journal of neurochemistry 2000;74(4):1773-6.
2000: Mouatt-Prigent A; Karlsson J O; Yelnik J; Agid Y; Hirsch E C
Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease.
The Journal of comparative neurology 2000;419(2):175-92.
2000: Damier P; Tremblay L; Féger J; Hirsch E C
[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)]
Revue neurologique 2000;156(3):224-35.
2000: Périer C; Vila M; Féger J; Agid Y; Hirsch E C
Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
Experimental neurology 2000;162(1):215-24.
2000: Hartmann A; Hunot S; Michel P P; Muriel M P; Vyas S; Faucheux B A; Mouatt-Prigent A; Turmel H; Srinivasan A; Ruberg M; Evan G I; Agid Y; Hirsch E C
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2875-80.
2000: Kubis N; Faucheux B A; Ransmayr G; Damier P; Duyckaerts C; Henin D; Forette B; Le Charpentier Y; Hauw J J; Agid Y; Hirsch E C
Preservation of midbrain catecholaminergic neurons in very old human subjects.
Brain : a journal of neurology 2000;123 ( Pt 2)():366-73.
2000: Vila M; Périer C; Féger J; Yelnik J; Faucheux B; Ruberg M; Raisman-Vozari R; Agid Y; Hirsch E C
Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements.
The European journal of neuroscience 2000;12(1):337-44.
2000: Murer M G; Dziewczapolski G; Salin P; Vila M; Tseng K Y; Ruberg M; Rubinstein M; Kelly M A; Grandy D K; Low M J; Hirsch E; Raisman-Vozari R; Gershanik O
The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice.
Neuroscience 2000;99(4):643-50.
2000: Orieux G; Francois C; Féger J; Yelnik J; Vila M; Ruberg M; Agid Y; Hirsch E C
Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease.
Neuroscience 2000;97(1):79-88.
1999: François C; Yelnik J; Tandé D; Agid Y; Hirsch E C
Dopaminergic cell group A8 in the monkey: anatomical organization and projections to the striatum.
The Journal of comparative neurology 1999;414(3):334-47.
1999: Damier P; Hirsch E C; Agid Y; Graybiel A M
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
Brain : a journal of neurology 1999;122 ( Pt 8)():1437-48.
1999: Damier P; Hirsch E C; Agid Y; Graybiel A M
The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
Brain : a journal of neurology 1999;122 ( Pt 8)():1421-36.
1999: Muriel M P; Bernard V; Levey A I; Laribi O; Abrous D N; Agid Y; Bloch B; Hirsch E C
Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease.
Annals of neurology 1999;46(1):103-11.
1999: Vila M; Marin C; Ruberg M; Jimenez A; Raisman-Vozari R; Agid Y; Tolosa E; Hirsch E C
Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
Journal of neurochemistry 1999;73(1):344-52.
1999: Hunot S; Dugas N; Faucheux B; Hartmann A; Tardieu M; Debré P; Agid Y; Dugas B; Hirsch E C
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(9):3440-7.
1999: Faucheux B A; Bonnet A M; Agid Y; Hirsch E C
Blood vessels change in the mesencephalon of patients with Parkinson's disease.
Lancet 1999;353(9157):981-2.
1999: Hirsch E; Hu L J; Prigent A; Constantin B; Agid Y; Drabkin H; Roche J
Distribution of semaphorin IV in adult human brain.
Brain research 1999;823(1-2):67-79.
1999: Hirsch E C; Hunot S; Faucheux B; Agid Y; Mizuno Y; Mochizuki H; Tatton W G; Tatton N; Olanow W C
Dopaminergic neurons degenerate by apoptosis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):383-5.
1999: Parain K; Murer M G; Yan Q; Faucheux B; Agid Y; Hirsch E; Raisman-Vozari R
Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.
Neuroreport 1999;10(3):557-61.
1999: Hirsch E C; Hunot S; Damier P; Brugg B; Faucheux B A; Michel P P; Ruberg M; Muriel M P; Mouatt-Prigent A; Agid Y
Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
Advances in neurology 1999;80():9-18.
1999: Hirsch E C
Mechanism and consequences of nerve cell death in Parkinson's disease.
Journal of neural transmission. Supplementum 1999;56():127-37.
1999: Murer M G; Boissiere F; Yan Q; Hunot S; Villares J; Faucheux B; Agid Y; Hirsch E; Raisman-Vozari R
An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.
Neuroscience 1999;88(4):1015-32.
1998: Trottier Y; Cancel G; An-Gourfinkel I; Lutz Y; Weber C; Brice A; Hirsch E; Mandel J L
Heterogeneous intracellular localization and expression of ataxin-3.
Neurobiology of disease 1998;5(5):335-47.
1998: Villares J; Faucheux B; Herrero M T; Obeso J A; Duyckaerts C; Hauw J J; Agid Y; Hirsch E C
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys.
Experimental neurology 1998;154(1):146-56.
1998: Benisty S; Boissiere F; Faucheux B; Agid Y; Hirsch E C
trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study.
Neuroscience 1998;86(3):813-26.
1998: Hartmann A; Hunot S; Hirsch E C
CD95 (APO-1/Fas) and Parkinson's disease.
Annals of neurology 1998;44(3):425-6.
1998: Hirsch E C; Hunot S; Damier P; Faucheux B
Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?
Annals of neurology 1998;44(3 Suppl 1):S115-20.
1998: Boissière F; Faucheux B; Duyckaerts C; Hauw J J; Agid Y; Hirsch E C
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease.
Journal of neurochemistry 1998;71(2):767-74.
1998: Faucheux B A; Hirsch E C
[Iron homeostasis and Parkinson's disease]
Annales de biologie clinique 1998;56 Spec No():23-30.
1998: Gourfinkel-An I; Cancel G; Duyckaerts C; Faucheux B; Hauw J J; Trottier Y; Brice A; Agid Y; Hirsch E C
Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Neuroreport 1998;9(8):1823-6.
1998: Holmberg M; Duyckaerts C; Dürr A; Cancel G; Gourfinkel-An I; Damier P; Faucheux B; Trottier Y; Hirsch E C; Agid Y; Brice A
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions.
Human molecular genetics 1998;7(5):913-8.
1998: Hirsch E C; Faucheux B A
Iron metabolism and Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1998;13 Suppl 1():39-45.
1998: Cancel G; Gourfinkel-An I; Stevanin G; Didierjean O; Abbas N; Hirsch E; Agid Y; Brice A
Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease.
Human mutation 1998;11(1):23-7.
1997: Gourfinkel-An I; Cancel G; Trottier Y; Devys D; Tora L; Lutz Y; Imbert G; Saudou F; Stevanin G; Agid Y; Brice A; Mandel J L; Hirsch E C
Differential distribution of the normal and mutated forms of huntingtin in the human brain.
Annals of neurology 1997;42(5):712-9.
1997: Ruberg M; France-Lanord V; Brugg B; Lambeng N; Michel P P; Anglade P; Hunot S; Damier P; Faucheux B; Hirsch E; Agid Y
[Neuronal death caused by apoptosis in Parkinson disease]
Revue neurologique 1997;153(8-9):499-508.
1997: Boissière F; Hunot S; Faucheux B; Duyckaerts C; Hauw J J; Agid Y; Hirsch E C
Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease.
Neuroreport 1997;8(13):2849-52.
1997: Anglade P; Vyas S; Hirsch E C; Agid Y
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging.
Histology and histopathology 1997;12(3):603-10.
1997: Hunot S; Brugg B; Ricard D; Michel P P; Muriel M P; Ruberg M; Faucheux B A; Agid Y; Hirsch E C
Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7531-6.
1997: Boissiere F; Faucheux B; Ruberg M; Agid Y; Hirsch E C
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.
Experimental neurology 1997;145(1):245-52.
1997: Ruberg M; Brugg B; Prigent A; Hirsch E; Brice A; Agid Y
Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
Journal of neurochemistry 1997;68(5):2098-110.
1997: Boissière F; Faucheux B; Agid Y; Hirsch E C
Choline acetyltransferase mRNA expression in the striatal neurons of patients with Alzheimer's disease.
Neuroscience letters 1997;225(3):169-72.
1997: Faucheux B A; Hauw J J; Agid Y; Hirsch E C
The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
Brain research 1997;749(1):170-4.
1997: Boissière F; Faucheux B; Agid Y; Hirsch E C
Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study.
Neuroscience letters 1997;221(2-3):141-4.
1997: Anglade P; Vyas S; Javoy-Agid F; Herrero M T; Michel P P; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch E C; Agid Y
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Histology and histopathology 1997;12(1):25-31.
1997: Levy R; Hazrati L N; Herrero M T; Vila M; Hassani O K; Mouroux M; Ruberg M; Asensi H; Agid Y; Féger J; Obeso J A; Parent A; Hirsch E C
Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states.
Neuroscience 1997;76(2):335-43.
1997: Boissière F; Hunot S; Faucheux B; Hersh L B; Agid Y; Hirsch E C
Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 1997;8(1):1-8.
1997: Vila M; Levy R; Herrero M T; Ruberg M; Faucheux B; Obeso J A; Agid Y; Hirsch E C
Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(2):765-73.
1997: Hirsch E C; Faucheux B; Damier P; Mouatt-Prigent A; Agid Y
Neuronal vulnerability in Parkinson's disease.
Journal of neural transmission. Supplementum 1997;50():79-88.
1996: Pezzoli G; Strada O; Silani V; Zecchinelli A; Perbellini L; Javoy-Agid F; Ghidoni P; Motti E D; Masini T; Scarlato G; Agid Y; Hirsch E C
Clinical and pathological features in hydrocarbon-induced parkinsonism.
Annals of neurology 1996;40(6):922-5.
1996: Herrero M T; Augood S J; Asensi H; Hirsch E C; Agid Y; Obeso J A; Emson P C
Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys.
Brain research. Molecular brain research 1996;42(1):149-55.
1996: Guridi J; Herrero M T; Luquin M R; Guillén J; Ruberg M; Laguna J; Vila M; Javoy-Agid F; Agid Y; Hirsch E; Obeso J A
Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.
Brain : a journal of neurology 1996;119 ( Pt 5)():1717-27.
1996: Agid Y; Hirsch E; Anglade P; Michel P; Brugg B; Ruberg M
Aging, disease and death of nerve cells.
Acta neurologica Belgica 1996;96(3):219-23.
1996: Boissière F; Pradier L; Delaère P; Faucheux B; Revah F; Brice A; Agid Y; Hirsch E C
Regional and cellular presenilin 2 (STM2) gene expression in the human brain.
Neuroreport 1996;7(12):2021-5.
1996: Mouatt-Prigent A; Karlsson J O; Agid Y; Hirsch E C
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
Neuroscience 1996;73(4):979-87.
1996: Herrero M T; Levy R; Ruberg M; Luquin M R; Villares J; Guillen J; Faucheux B; Javoy-Agid F; Guridi J; Agid Y; Obeso J A; Hirsch E C
Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum.
Neurology 1996;47(1):219-24.
1996: Anglade P; Mouatt-Prigent A; Agid Y; Hirsch E
Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1996;5(2):121-8.
1996: Boissière F; Lehéricy S; Strada O; Agid Y; Hirsch E C
Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1996;28(1-3):219-23.
1996: Bernard V; Gardiol A; Faucheux B; Bloch B; Agid Y; Hirsch E C
Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion.
The Journal of comparative neurology 1996;368(4):553-68.
1996: Hunot S; Boissière F; Faucheux B; Brugg B; Mouatt-Prigent A; Agid Y; Hirsch E C
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.
Neuroscience 1996;72(2):355-63.
1996: Damier P; Kastner A; Agid Y; Hirsch E C
Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease?
Neurology 1996;46(5):1262-9.
1996: Vila M; Levy R; Herrero M T; Faucheux B; Obeso J A; Agid Y; Hirsch E C
Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.
Neuroscience 1996;71(4):903-12.
1996: Vila M; Herrero M T; Levy R; Faucheux B; Ruberg M; Guillen J; Luquin M R; Guridi J; Javoy-Agid F; Agid Y; Obeso J A; Hirsch E C
Consequences of nigrostriatal denervation on the gamma-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes.
Neurology 1996;46(3):802-9.
1996: Hunot S; Bernard V; Faucheux B; Boissière F; Leguern E; Brana C; Gautris P P; Guérin J; Bloch B; Agid Y; Hirsch E C
Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(8-9):1043-52.
1996: Leveugle B; Faucheux B A; Bouras C; Nillesse N; Spik G; Hirsch E C; Agid Y; Hof P R
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.
Acta neuropathologica 1996;91(6):566-72.
1996: Herrero M T; Levy R; Ruberg M; Javoy-Agid F; Luquin M R; Agid Y; Hirsch E C; Obeso J A
Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.
Advances in neurology 1996;69():209-16.
1996: Anglade P; Blanchard V; Raisman-Vozari R; Faucheux B A; Herrero M T; Obeso J A; Mouatt-Prigent A; Kastner A; Strada O; Javoy-Agid F; Agid Y; Hirsch E C
Is dopaminergic cell death accompanied by concomitant nerve plasticity?
Advances in neurology 1996;69():195-208.
1995: Levy R; Vila M; Herrero M T; Faucheux B; Agid Y; Hirsch E C
Striatal expression of substance P and methionin-enkephalin in genes in patients with Parkinson's disease.
Neuroscience letters 1995;199(3):220-4.
1995: Herrero M T; Augood S J; Hirsch E C; Javoy-Agid F; Luquin M R; Agid Y; Obeso J A; Emson P C
Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum.
Neuroscience 1995;68(4):1189-98.
1995: Faucheux B A; Herrero M T; Villares J; Levy R; Javoy-Agid F; Obeso J A; Hauw J J; Agid Y; Hirsch E C
Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
Brain research 1995;691(1-2):115-24.
1995: Thibaut F; Faucheux B A; Marquez J; Villares J; Menard J F; Agid Y; Hirsch E C
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
Brain research 1995;692(1-2):233-43.
1995: Trottier Y; Devys D; Imbert G; Saudou F; An I; Lutz Y; Weber C; Agid Y; Hirsch E C; Mandel J L
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.
Nature genetics 1995;10(1):104-10.
1995: Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch E C
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Annals of neurology 1995;37(2):265-72.
1995: Anglade P; Tsuji S; Agid Y; Hirsch E C
Neuronal plasticity and Parkinson disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1995;24(2-3):251-5.
1995: Levy R; Ruberg M; Herrero M T; Villares J; Javoy-Agid F; Agid Y; Hirsch E C
Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.
Neurology 1995;45(1):127-34.
1994: Mouatt-Prigent A; Agid Y; Hirsch E C
Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
Brain research 1994;668(1-2):62-70.
1994: Villares J; Strada O; Faucheux B; Javoy-Agid F; Agid Y; Hirsch E C
Loss of striatal high affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease.
Neuroscience letters 1994;182(1):59-62.
1994: Boissière F; Hunot S; Faucheux B; Mouatt-Prigent A; Agid Y; Hirsch E C
High affinity neurotrophin receptors in cholinergic neurons in the human brain.
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1994;317(11):997-1003.
1994: Lehéricy S; Brandel J P; Hirsch E C; Anglade P; Villares J; Scherman D; Duyckaerts C; Javoy-Agid F; Agid Y
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Brain research 1994;659(1-2):1-9.
1994: Kastner A; Anglade P; Bounaix C; Damier P; Javoy-Agid F; Bromet N; Agid Y; Hirsch E C
Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system.
Neuroscience 1994;62(2):449-57.
1994: Kastner A; Herrero M T; Hirsch E C; Guillen J; Luquin M R; Javoy-Agid F; Obeso J A; Agid Y
Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Annals of neurology 1994;36(2):206-14.
1994: Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
Neuroscience 1994;61(4):755-64.
1994: Zhang P; Anglade P; Hirsch E C; Javoy-Agid F; Agid Y
Distribution of manganese-dependent superoxide dismutase in the human brain.
Neuroscience 1994;61(2):317-30.
1994: Boka G; Anglade P; Wallach D; Javoy-Agid F; Agid Y; Hirsch E C
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.
Neuroscience letters 1994;172(1-2):151-4.
1994: Malessa S; Gaymard B; Rivaud S; Cervera P; Hirsch E; Verny M; Duyckaerts C; Agid Y; Pierrot-Deseilligny C
Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study.
Neurology 1994;44(4):716-21.
1993: Strada O; Hirsch E C; Javoy-Agid F; Duyckaerts C; Hauw J J; Agid Y
Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease.
Journal of the neurological sciences 1993;120(1):33-7.
1993: Villares J; Faucheux B; Strada O; Hirsch E C; Agid Y; Javoy-Agid F
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem.
Brain research 1993;628(1-2):72-6.
1993: Herrero M T; Kastner A; Perez-Otaño I; Hirsch E C; Luquin M R; Javoy-Agid F; Del Río J; Obeso J A; Agid Y
Gangliosides and parkinsonism.
Neurology 1993;43(10):2132-4.
1993: Herrero M T; Perez-Otaño I; Oset C; Kastner A; Hirsch E C; Agid Y; Luquin M R; Obeso J A; Del Rio J
GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
Neuroscience 1993;56(4):965-72.
1993: Herrero M T; Hirsch E C; Javoy-Agid F; Obeso J A; Agid Y
Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum.
Brain research 1993;624(1-2):281-5.
1993: Herrero M T; Hirsch E C; Kastner A; Ruberg M; Luquin M R; Laguna J; Javoy-Agid F; Obeso J A; Agid Y
Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Neuroscience 1993;56(2):499-511.
1993: Kastner A; Hirsch E C; Herrero M T; Javoy-Agid F; Agid Y
Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease.
Journal of neurochemistry 1993;61(3):1024-34.
1993: Blanchard V; Raisman-Vozari R; Savasta M; Hirsch E; Javoy-Agid F; Feuerstein C; Agid Y
Cellular quantification of tyrosine hydroxylase in the rat brain by immunoautoradiography.
Journal of neurochemistry 1993;61(2):617-26.
1993: Zhang P; Damier P; Hirsch E C; Agid Y; Ceballos-Picot I; Sinet P M; Nicole A; Laurent M; Javoy-Agid F
Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon.
Neuroscience 1993;55(1):167-75.
1993: Herrero M T; Ruberg M; Hirsch E C; Mouatt A; Tobin A J; Agid Y; Obeso J A; Javoy-Agid F
In situ hybridization of GAD mRNA in monkey and human brain: quantification at both regional and cellular levels.
Neuroscience letters 1993;157(1):57-61.
1993: Anglade P; Tsuji S; Hirsch E C; Javoy-Agid F; Agid Y
Ultrastructural relations between nigrostriatal dopaminergic neurons and cholinergic nerve endings in the human brain.
Histology and histopathology 1993;8(3):501-4.
1993: Faucheux B A; Hirsch E C; Villares J; Selimi F; Mouatt-Prigent A; Javoy-Agid F; Hauw J J; Agid Y
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
Journal of neurochemistry 1993;60(6):2338-41.
1993: Anglade P; Hirsch E C; Brandel J P; Javoy-Agid F; Duyckaerts C; Hauw J J; Agid Y
Adrenal transplant, dopaminergic neurons, and Parkinson's disease.
Annals of neurology 1993;33(6):662-3.
1993: Lehéricy S; Hirsch E C; Cervera-Piérot P; Hersh L B; Bakchine S; Piette F; Duyckaerts C; Hauw J J; Javoy-Agid F; Agid Y
Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
The Journal of comparative neurology 1993;330(1):15-31.
1993: Kastner A; Hirsch E C; Agid Y; Javoy-Agid F
Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
Brain research 1993;606(2):341-5.
1993: Damier P; Hirsch E C; Zhang P; Agid Y; Javoy-Agid F
Glutathione peroxidase, glial cells and Parkinson's disease.
Neuroscience 1993;52(1):1-6.
1993: Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Advances in neurology 1993;60():148-64.
1993: Hirsch E C
Does oxidative stress participate in nerve cell death in Parkinson's disease?
European neurology 1993;33 Suppl 1():52-9.
1993: Herrero M T; Hirsch E C; Kastner A; Luquin M R; Javoy-Agid F; Gonzalo L M; Obeso J A; Agid Y
Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.
Developmental neuroscience 1993;15(1):37-48.
1992: Strada O; Hirsch E C; Javoy-Agid F; Lehéricy S; Ruberg M; Hauw J J; Agid Y
Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992;12(12):4766-74.
1992: Strada O; Vyas S; Hirsch E C; Ruberg M; Brice A; Agid Y; Javoy-Agid F
Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(20):9549-53.
1992: Kastner A; Hirsch E C; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
Journal of neurochemistry 1992;59(3):1080-9.
1992: Hirsch E C; Mouatt A; Faucheux B; Bonnet A M; Javoy-Agid F; Graybiel A M; Agid Y
Dopamine, tremor, and Parkinson's disease.
Lancet 1992;340(8811):125-6.
1992: Zhang P; Hirsch E C; Damier P; Duyckaerts C; Javoy-Agid F
c-fos protein-like immunoreactivity: distribution in the human brain and over-expression in the hippocampus of patients with Alzheimer's disease.
Neuroscience 1992;46(1):9-21.
1992: Hirsch E C
Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
Annals of neurology 1992;32 Suppl():S88-93.
1992: Ransmayr G; Cervera P; Hirsch E C; Berger W; Fischer W; Agid Y
Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology?
Neuroscience 1992;47(4):843-51.
1991: Malessa S; Hirsch E C; Cervera P; Javoy-Agid F; Duyckaerts C; Hauw J J; Agid Y
Progressive supranuclear palsy: loss of choline-acetyltransferase-like immunoreactive neurons in the pontine reticular formation.
Neurology 1991;41(10):1593-7.
1991: Raisman-Vozari R; Hirsch E; Javoy-Agid F; Vassort C; Savasta M; Feuerstein C; Thibault J; Agid Y
Quantitative autoradiography of tyrosine hydroxylase immunoreactivity in the rat brain.
Journal of neurochemistry 1991;57(4):1212-22.
1991: Hirsch E C; Brandel J P; Galle P; Javoy-Agid F; Agid Y
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Journal of neurochemistry 1991;56(2):446-51.
1991: Lehéricy S; Hirsch E C; Hersh L B; Agid Y
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients.
Neuroscience letters 1991;123(2):152-5.
1991: Juncos J L; Hirsch E C; Malessa S; Duyckaerts C; Hersh L B; Agid Y
Mesencephalic cholinergic nuclei in progressive supranuclear palsy.
Neurology 1991;41(1):25-30.
1991: Ceballos I; Javoy-Agid F; Delacourte A; Defossez A; Lafon M; Hirsch E; Nicole A; Sinet P M; Agid Y
Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains.
Free radical research communications 1991;12-13 Pt 2():571-80.
1991: Brandel J P; Hirsch E C; Malessa S; Duyckaerts C; Cervera P; Agid Y
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy.
Neuroscience 1991;41(1):25-31.
1990: Malessa S; Hirsch E C; Cervera P; Duyckaerts C; Agid Y
Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.
Neurology 1990;40(11):1739-43.
1990: Hirsch E C; Duyckaerts C; Javoy-Agid F; Hauw J J; Agid Y
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
Annals of neurology 1990;27(6):676-82.
1990: Brandel J P; Hirsch E C; Hersh L B; Javoy-Agid F
Compartmental ordering of cholinergic innervation in the mediodorsal nucleus of the thalamus in human brain.
Brain research 1990;515(1-2):117-25.
1990: Dumas S; Javoy-Agid F; Hirsch E; Agid Y; Mallet J
Tyrosine hydroxylase gene expression in human ventral mesencephalon: detection of tyrosine hydroxylase messenger RNA in neurites.
Journal of neuroscience research 1990;25(4):569-75.
1990: Ceballos I; Lafon M; Javoy-Agid F; Hirsch E; Nicole A; Sinet P M; Agid Y
Superoxide dismutase and Parkinson's disease.
Lancet 1990;335(8696):1035-6.
1990: Cervera P; Duyckaerts C; Ruberg M; Hirsch E; Ransmayr G; Hauw J J; Agid Y
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's disease.
Neuroscience letters 1990;110(1-2):210-5.
1990: Thibaut F; Hirsch E C; Raisman R; Javoy-Agid F; Agid Y
Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
Neuroscience 1990;37(2):387-98.
1990: Javoy-Agid F; Hirsch E C; Dumas S; Duyckaerts C; Mallet J; Agid Y
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.
Neuroscience 1990;38(1):245-53.
1990: Agid Y; Graybiel A M; Ruberg M; Hirsch E; Blin J; Dubois B; Javoy-Agid F
The efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
Advances in neurology 1990;53():83-100.
1990: Graybiel A M; Hirsch E C; Agid Y
The nigrostriatal system in Parkinson's disease.
Advances in neurology 1990;53():17-29.
1989: Lehéricy S; Hirsch E C; Cervera P; Hersh L B; Hauw J J; Ruberg M; Agid Y
Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(21):8580-4.
1989: Ceballos I; Javoy-Agid F; Hirsch E C; Dumas S; Kamoun P P; Sinet P M; Agid Y
Localization of copper-zinc superoxide dismutase mRNA in human hippocampus by in situ hybridization.
Neuroscience letters 1989;105(1-2):41-6.
1989: Hirsch E C; Graybiel A M; Hersh L B; Duyckaerts C; Agid Y
Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum.
Neuroscience letters 1989;96(2):145-50.
1989: Ransmayr G; Cervera P; Hirsch E; Ruberg M; Hersh L B; Duyckaerts C; Hauw J J; Delumeau C; Agid Y
Choline acetyltransferase-like immunoreactivity in the hippocampal formation of control subjects and patients with Alzheimer's disease.
Neuroscience 1989;32(3):701-14.
1989: Hirsch E C; Graybiel A M; Agid Y
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.
Acta neurologica Scandinavica. Supplementum 1989;126():19-22.
1989: Agid Y; Cervera P; Hirsch E; Javoy-Agid F; Lehericy S; Raisman R; Ruberg M
Biochemistry of Parkinson's disease 28 years later: a critical review.
Movement disorders : official journal of the Movement Disorder Society 1989;4 Suppl 1():S126-44.
1988: Hirsch E; Graybiel A M; Agid Y A
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
Nature 1988;334(6180):345-8.
1988: Hirsch E; Ruberg M; Portier M M; Dardenne M; Agid Y
Characterization of two antigens in parkinsonian Lewy bodies.
Brain research 1988;441(1-2):139-44.
1987: Epelbaum J; Javoy-Agid F; Hirsch E; Hauw J J; Kordon C; Krantic S; Agid Y
Brain somatostatin concentrations do not decrease in progressive supranuclear palsy.
Journal of neurology, neurosurgery, and psychiatry 1987;50(11):1526-8.
1987: Hirsch E C; Graybiel A M; Duyckaerts C; Javoy-Agid F
Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(16):5976-80.
1987: Graybiel A M; Hirsch E C; Agid Y A
Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(1):303-7.
1987: Delisle M B; Gorce P; Hirsch E; Hauw J J; Rascol A; Bouissou H
Motor neuron disease, parkinsonism and dementia. Report of a case with diffuse Lewy body-like intracytoplasmic inclusions.
Acta neuropathologica 1987;75(1):104-8.
1985: Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw J J; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
Annals of neurology 1985;18(5):523-9.
1985: Hirsch E; Ruberg M; Dardenne M; Portier M M; Javoy-Agid F; Bach J F; Agid Y
Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
Brain research 1985;345(2):374-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Etienne Hirsch

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Procedures

Living Beings

Physiology

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Etienne Hirsch (preview)

All Publications